ID   CO4A5_HUMAN             Reviewed;        1685 AA.
AC   P29400; Q16006; Q16126; Q6LD84; Q7Z700; Q9NUB7;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1994, sequence version 2.
DT   22-FEB-2012, entry version 146.
DE   RecName: Full=Collagen alpha-5(IV) chain;
DE   Flags: Precursor;
GN   Name=COL4A5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   MEDLINE=94165049; PubMed=8120014;
RA   Zhou J., Leinonen A., Tryggvason K.;
RT   "Structure of the human type IV collagen COL4A5 gene.";
RL   J. Biol. Chem. 269:6608-6614(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A.,
RA   Lovell F.L., Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G.,
RA   Jones M.C., Hurles M.E., Andrews T.D., Scott C.E., Searle S.,
RA   Ramser J., Whittaker A., Deadman R., Carter N.P., Hunt S.E., Chen R.,
RA   Cree A., Gunaratne P., Havlak P., Hodgson A., Metzker M.L.,
RA   Richards S., Scott G., Steffen D., Sodergren E., Wheeler D.A.,
RA   Worley K.C., Ainscough R., Ambrose K.D., Ansari-Lari M.A., Aradhya S.,
RA   Ashwell R.I., Babbage A.K., Bagguley C.L., Ballabio A., Banerjee R.,
RA   Barker G.E., Barlow K.F., Barrett I.P., Bates K.N., Beare D.M.,
RA   Beasley H., Beasley O., Beck A., Bethel G., Blechschmidt K., Brady N.,
RA   Bray-Allen S., Bridgeman A.M., Brown A.J., Brown M.J., Bonnin D.,
RA   Bruford E.A., Buhay C., Burch P., Burford D., Burgess J., Burrill W.,
RA   Burton J., Bye J.M., Carder C., Carrel L., Chako J., Chapman J.C.,
RA   Chavez D., Chen E., Chen G., Chen Y., Chen Z., Chinault C.,
RA   Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J.,
RA   Delgado O., Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S.,
RA   Draper H., Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I.,
RA   Eades T., Ellwood M., Emery-Cohen A., Errington H., Evans K.L.,
RA   Faulkner L., Francis F., Frankland J., Fraser A.E., Galgoczy P.,
RA   Gilbert J., Gill R., Gloeckner G., Gregory S.G., Gribble S.,
RA   Griffiths C., Grocock R., Gu Y., Gwilliam R., Hamilton C., Hart E.A.,
RA   Hawes A., Heath P.D., Heitmann K., Hennig S., Hernandez J.,
RA   Hinzmann B., Ho S., Hoffs M., Howden P.J., Huckle E.J., Hume J.,
RA   Hunt P.J., Hunt A.R., Isherwood J., Jacob L., Johnson D., Jones S.,
RA   de Jong P.J., Joseph S.S., Keenan S., Kelly S., Kershaw J.K., Khan Z.,
RA   Kioschis P., Klages S., Knights A.J., Kosiura A., Kovar-Smith C.,
RA   Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L., Liu W.,
RA   Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T.,
RA   Milne S., Miner G., Mistry S.L., Morgan M., Morris S., Mueller I.,
RA   Mullikin J.C., Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N.,
RA   Okwuonu G., Palmer S., Pandian R., Parker D., Parrish J.,
RA   Pasternak S., Patel D., Pearce A.V., Pearson D.M., Pelan S.E.,
RA   Perez L., Porter K.M., Ramsey Y., Reichwald K., Rhodes S.,
RA   Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T.,
RA   Teague B., Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S.,
RA   Tromans A.C., d'Urso M., Verduzco D., Villasana D., Waldron L.,
RA   Wall M., Wang Q., Warren J., Warry G.L., Wei X., West A.,
RA   Whitehead S.L., Whiteley M.N., Wilkinson J.E., Willey D.L.,
RA   Williams G., Williams L., Williamson A., Williamson H., Wilming L.,
RA   Woodmansey R.L., Wray P.W., Yen J., Zhang J., Zhou J., Zoghbi H.,
RA   Zorilla S., Buck D., Reinhardt R., Poustka A., Rosenthal A.,
RA   Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A.,
RA   Nelson D.L., Weinstock G., Sulston J.E., Durbin R.M., Hubbard T.,
RA   Gibbs R.A., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE OF 1-910, AND VARIANT APSX CYS-521.
RC   TISSUE=Kidney;
RX   MEDLINE=92316923; PubMed=1352287;
RA   Zhou J., Hertz J.M., Leinonen A., Tryggvason K.;
RT   "Complete amino acid sequence of the human alpha 5 (IV) collagen chain
RT   and identification of a single-base mutation in exon 23 converting
RT   glycine 521 in the collagenous domain to cysteine in an Alport
RT   syndrome patient.";
RL   J. Biol. Chem. 267:12475-12481(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 85-1685.
RC   TISSUE=Placenta;
RX   MEDLINE=90337990; PubMed=2380186;
RA   Pihlajaniemi T., Pohjolainen E.R., Myers J.C.;
RT   "Complete primary structure of the triple-helical region and the
RT   carboxyl-terminal domain of a new type IV collagen chain, alpha
RT   5(IV).";
RL   J. Biol. Chem. 265:13758-13766(1990).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 924-1685.
RX   MEDLINE=91169491; PubMed=2004755; DOI=10.1016/0888-7543(91)90214-Y;
RA   Zhou J., Hostikka S.L., Chow L.T., Tryggvason K.;
RT   "Characterization of the 3' half of the human type IV collagen alpha 5
RT   gene that is affected in the Alport syndrome.";
RL   Genomics 9:1-9(1991).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 914-1685.
RX   MEDLINE=90160375; PubMed=1689491; DOI=10.1073/pnas.87.4.1606;
RA   Hostikka S.L., Eddy R.L., Byers M.G., Hoeyhtyae M., Shows T.B.,
RA   Tryggvason K.;
RT   "Identification of a distinct type IV collagen alpha chain with
RT   restricted kidney distribution and assignment of its gene to the locus
RT   of X chromosome-linked Alport syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:1606-1610(1990).
RN   [8]
RP   NUCLEOTIDE SEQUENCE OF 1442-1471.
RX   MEDLINE=90252791; PubMed=2339699;
RA   Myers J.C., Jones T.A., Pohjolainen E.R., Kadri A.S., Goddard A.D.,
RA   Sheer D., Solomon E., Pihlajaniemi T.;
RT   "Molecular cloning of alpha 5(IV) collagen and assignment of the gene
RT   to the region of the X chromosome containing the Alport syndrome
RT   locus.";
RL   Am. J. Hum. Genet. 46:1024-1033(1990).
RN   [9]
RP   NUCLEOTIDE SEQUENCE OF 1-20.
RA   Guo C., van Damme B., Vanrenterghem Y., Devriendt K., Cassiman J.-J.,
RA   Marynen P.;
RL   Submitted (SEP-1994) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE OF 1258-1270 (ISOFORM 2).
RX   MEDLINE=94133540; PubMed=8301933; DOI=10.1038/ki.1993.384;
RA   Guo C., van Damme B., van Damme-Lombaerts R., van den Berghe H.,
RA   Cassiman J.-J., Marynen P.;
RT   "Differential splicing of COL4A5 mRNA in kidney and white blood cells:
RT   a complex mutation in the COL4A5 gene of an Alport patient deletes the
RT   NC1 domain.";
RL   Kidney Int. 44:1316-1321(1993).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1589-1598 AND 1677-1685, AND
RP   VARIANTS APSX 1597-TYR--THR-1685 DEL AND 1679-GLQ--THR-1685 DEL.
RX   PubMed=7853788; DOI=10.1038/ki.1994.399;
RA   Nakazato H., Hattori S., Ushijima T., Matsuura T., Koitabashi Y.,
RA   Takada T., Yoshioka K., Endo F., Matsuda I.;
RT   "Mutations in the COL4A5 gene in Alport syndrome: a possible mutation
RT   in primordial germ cells.";
RL   Kidney Int. 46:1307-1314(1994).
RN   [12]
RP   REVIEW ON VARIANTS.
RX   MEDLINE=97338662; PubMed=9195222;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:6<477::AID-HUMU1>3.3.CO;2-H;
RA   Lemmink H.H., Schroeder C.H., Monnens L.A.H., Smeets H.J.M.;
RT   "The clinical spectrum of type IV collagen mutations.";
RL   Hum. Mutat. 9:477-499(1997).
RN   [13]
RP   VARIANT APSX SER-1564.
RX   MEDLINE=91169492; PubMed=1672282; DOI=10.1016/0888-7543(91)90215-Z;
RA   Zhou J., Barker D.F., Hostikka S.L., Gregory M.C., Atkin C.L.,
RA   Tryggvason K.;
RT   "Single base mutation in alpha 5(IV) collagen chain gene converting a
RT   conserved cysteine to serine in Alport syndrome.";
RL   Genomics 9:10-18(1991).
RN   [14]
RP   VARIANT APSX ARG-325.
RX   MEDLINE=92303559; PubMed=1376965;
RA   Knebelmann B., Deschenes G., Gros F., Hors M.-C., Gruenfeld J.-P.,
RA   Tryggvason K., Gubler M.-C., Antignac C.;
RT   "Substitution of arginine for glycine 325 in the collagen alpha 5 (IV)
RT   chain associated with X-linked Alport syndrome: characterization of
RT   the mutation by direct sequencing of PCR-amplified lymphoblast cDNA
RT   fragments.";
RL   Am. J. Hum. Genet. 51:135-142(1992).
RN   [15]
RP   VARIANT APSX GLU-325.
RX   MEDLINE=93244772; PubMed=1363780; DOI=10.1093/hmg/1.2.127;
RA   Renieri A., Seri M., Myers J.C., Pihlajaniemi T., Massella L.,
RA   Rizzoni G.F., de Marchi M.;
RT   "De novo mutation in the COL4A5 gene converting glycine 325 to
RT   glutamic acid in Alport syndrome.";
RL   Hum. Mol. Genet. 1:127-129(1992).
RN   [16]
RP   VARIANTS APSX THR-1517; SER-1538 AND GLN-1563.
RX   MEDLINE=94010948; PubMed=8406498; DOI=10.1006/geno.1993.1351;
RA   Lemmink H.L., Schroeder C.H., Brunner H.G., Nelen M.R., Zhou J.,
RA   Tryggvason K., Haggsma-Schouten W.A.G., Roodvoets A.P., Rascher W.,
RA   van Oost B.A., Smeets H.J.M.;
RT   "Identification of four novel mutations in the COL4A5 gene of patients
RT   with Alport syndrome.";
RL   Genomics 17:485-489(1993).
RN   [17]
RP   INVOLVEMENT IN DL-ATS.
RX   MEDLINE=93361972; PubMed=8356449; DOI=10.1126/science.8356449;
RA   Zhou J., Mochizuki T., Smeets H., Antignac C., Laurila P.,
RA   de Paepe A., Tryggvason K., Reeders S.T.;
RT   "Deletion of the paired alpha 5(IV) and alpha 6(IV) collagen genes in
RT   inherited smooth muscle tumors.";
RL   Science 261:1167-1169(1993).
RN   [18]
RP   VARIANTS APSX GLU-400; VAL-406; VAL-638; ALA-638; ARG-653; ARG-796;
RP   ARG-869; ARG-872 AND CYS-1241.
RX   MEDLINE=95322976; PubMed=7599631; DOI=10.1002/humu.1380050303;
RA   Boye E., Flinter F., Zhou J., Tryggvason K., Bobrow M., Harris A.;
RT   "Detection of 12 novel mutations in the collagenous domain of the
RT   COL4A5 gene in Alport syndrome patients.";
RL   Hum. Mutat. 5:197-204(1995).
RN   [19]
RP   VARIANT APSX ARG-1649.
RX   MEDLINE=96213750; PubMed=8651292;
RA   Barker D.F., Pruchno C.J., Jiang X., Atkin C.L., Stone E.M.,
RA   Denison J.C., Fain P.R., Gregory M.C.;
RT   "A mutation causing Alport syndrome with tardive hearing loss is
RT   common in the western United States.";
RL   Am. J. Hum. Genet. 58:1157-1165(1996).
RN   [20]
RP   VARIANTS APSX.
RX   MEDLINE=96213754; PubMed=8651296;
RA   Renieri A., Bruttini M., Galli L., Zanelli P., Neri T.M., Rossetti S.,
RA   Turco A.E., Heiskari N., Zhou J., Gusmano R., Massella L., Banfi G.,
RA   Scolari F., Sessa A., Rizzoni G.F., Tryggvason K., Pignatti P.F.,
RA   Savi M., Ballabio A., de Marchi M.;
RT   "X-linked Alport syndrome: an SSCP-based mutation survey over all 51
RT   exons of the COL4A5 gene.";
RL   Am. J. Hum. Genet. 58:1192-1204(1996).
RN   [21]
RP   VARIANTS APSX, AND VARIANTS ASP-430; SER-444; SER-619; ASN-664 AND
RP   MET-1428.
RX   MEDLINE=97094179; PubMed=8940267;
RA   Knebelmann B., Breillat C., Forestier L., Arrondel C., Jacassier D.,
RA   Giatras I., Drouot L., Deschenes G., Gruenfeld J.-P., Broyer M.,
RA   Gubler M.-C., Antignac C.;
RT   "Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport
RT   syndrome.";
RL   Am. J. Hum. Genet. 59:1221-1232(1996).
RN   [22]
RP   VARIANT APSX ASP-1498.
RX   MEDLINE=96233932; PubMed=8829632;
RX   DOI=10.1002/(SICI)1098-1004(1996)7:2<149::AID-HUMU9>3.3.CO;2-A;
RA   Tverskaya S., Bobrynina V., Tsalykova F., Ignatova M.,
RA   Krasnopolskaya X., Evgrafov O.;
RT   "Substitution of A1498D in noncollagen domain of a5(IV) collagen chain
RT   associated with adult-onset X-linked Alport syndrome.";
RL   Hum. Mutat. 7:149-150(1996).
RN   [23]
RP   VARIANT APSX GLN-1677.
RX   MEDLINE=97295089; PubMed=9150741; DOI=10.1007/s004390050429;
RA   Barker D.F., Denison J.C., Atkin C.L., Gregory M.C.;
RT   "Common ancestry of three Ashkenazi-American families with Alport
RT   syndrome and COL4A5 R1677Q.";
RL   Hum. Genet. 99:681-684(1997).
RN   [24]
RP   VARIANTS APSX ARG-174; ARG-177; ARG-325; CYS-1410; TRP-1421; THR-1517
RP   AND ASP-1596.
RX   MEDLINE=98112435; PubMed=9452056;
RA   Neri T.M., Zanelli P., de Palma G., Savi M., Rossetti S., Turco A.E.,
RA   Pignatti G.F., Galli L., Bruttini M., Renieri A., Mingarelli R.,
RA   Trivelli A., Pinciaroli A.R., Ragaiolo M., Rizzoni G.F., de Marchi M.;
RT   "Missense mutations in the COL4A5 gene in patients with X-linked
RT   Alport syndrome.";
RL   Hum. Mutat. Suppl. 1:S106-S109(1998).
RN   [25]
RP   VARIANTS APSX VAL-420; 456-PRO--PRO-458 DEL; ASP-573; ASP-624;
RP   ASP-635; 802-GLY--PRO-807 DEL; ARG-869; CYS-941; SER-1030; SER-1066;
RP   ASP-1143; ARG-1196; GLU-1261; SER-1357 AND ARG-1649.
RX   MEDLINE=99063529; PubMed=9848783;
RA   Martin P., Heiskari N., Zhou J., Leinonen A., Tumelius T., Hertz J.M.,
RA   Barker D.F., Gregory M.C., Atkin C.L., Styrkarsdottir U., Neumann H.,
RA   Springate J., Shows T.B., Pettersson E., Tryggvason K.;
RT   "High mutation detection rate in the COL4A5 collagen gene in suspected
RT   Alport syndrome using PCR and direct DNA sequencing.";
RL   J. Am. Soc. Nephrol. 9:2291-2301(1998).
RN   [26]
RP   VARIANTS APSX GLU-579; LYS-633; ASP-947; VAL-953; ARG-1107; ARG-1158;
RP   SER-1170 AND TRP-1678, AND VARIANTS SER-444 AND ALA-739.
RX   MEDLINE=20030197; PubMed=10561141;
RA   Inoue Y., Nishio H., Shirakawa T., Nakanishi K., Nakamura H.,
RA   Sumino K., Nishiyama K., Iijima K., Yoshikawa N.;
RT   "Detection of mutations in the COL4A5 gene in over 90% of male
RT   patients with X-linked Alport's syndrome by RT-PCR and direct
RT   sequencing.";
RL   Am. J. Kidney Dis. 34:854-862(1999).
RN   [27]
RP   VARIANT APSX ARG-822.
RX   MEDLINE=20025011; PubMed=10563487;
RX   DOI=10.1034/j.1399-0004.1999.560312.x;
RA   Cruz-Robles D., Garcia-Torres R., Antignac C., Forestier L.,
RA   Garcia de la Puente S., Correa-Rotter R., Garcia-Lopez E., Orozco L.;
RT   "Three novel mutations in the COL4A5 gene in Mexican Alport syndrome
RT   patients.";
RL   Clin. Genet. 56:242-243(1999).
RN   [28]
RP   VARIANTS APSX, AND VARIANTS.
RX   MEDLINE=99140256; PubMed=10094548;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:2<124::AID-HUMU4>3.0.CO;2-Z;
RA   Plant K.E., Green P.M., Vetrie D., Flinter F.A.;
RT   "Detection of mutations in COL4A5 in patients with Alport syndrome.";
RL   Hum. Mutat. 13:124-132(1999).
RN   [29]
RP   VARIANT APSX CYS-177.
RX   MEDLINE=20460632; PubMed=11004279; DOI=10.1016/S0002-9394(00)00466-9;
RA   Blasi M.A., Rinaldi R., Renieri A., Petrucci R., De Bernardo C.,
RA   Bruttini M., Grammatico P.;
RT   "Dot-and-fleck retinopathy in Alport syndrome caused by a novel
RT   mutation in the COL4A5 gene.";
RL   Am. J. Ophthalmol. 130:130-131(2000).
RN   [30]
RP   VARIANTS APSX ARG-216; ARG-415; GLU-1045; ASP-1086; SER-1167 AND
RP   864-SER--GLY-875 DEL.
RX   MEDLINE=20321306; PubMed=10862091;
RX   DOI=10.1002/1098-1004(200006)15:6<579::AID-HUMU13>3.3.CO;2-B;
RA   Martin P., Heiskari N., Pajari H., Groenhagen-Riska C.,
RA   Kaeaeriaeinen H., Koskimies O., Tryggvason K.;
RT   "Spectrum of COL4A5 mutations in Finnish Alport syndrome patients.";
RL   Hum. Mutat. 15:579-579(2000).
RN   [31]
RP   VARIANTS APSX ARG-319; SER-739; VAL-902; GLU-911; ASP-1229 AND
RP   HIS-1511.
RX   MEDLINE=20148403; PubMed=10684360; DOI=10.1007/s004670050025;
RA   Cheong H.I., Park H.W., Ha I.S., Choi Y.;
RT   "Mutational analysis of COL4A5 gene in Korean Alport syndrome.";
RL   Pediatr. Nephrol. 14:117-121(2000).
RN   [32]
RP   VARIANTS APSX ARG-192; ARG-292; ASP-295; ARG-325; ARG-558; VAL-603;
RP   ASP-624; ASP-629; GLU-722; VAL-898; ALA-1006; VAL-1006; ASP-1244;
RP   ARG-1649 AND PRO-1677, AND VARIANT SER-444.
RX   MEDLINE=21123908; PubMed=11223851;
RX   DOI=10.1002/1096-8628(20010115)98:2<148::AID-AJMG1024>3.0.CO;2-W;
RA   Barker D.F., Denison J.C., Atkin C.L., Gregory M.C.;
RT   "Efficient detection of Alport syndrome COL4A5 mutations with
RT   multiplex genomic PCR-SSCP.";
RL   Am. J. Med. Genet. 98:148-160(2001).
RN   [33]
RP   INVOLVEMENT IN DL-ATS.
RX   PubMed=12784310; DOI=10.1002/ajmg.a.20019;
RA   Anker M.C., Arnemann J., Neumann K., Ahrens P., Schmidt H., Koenig R.;
RT   "Alport syndrome with diffuse leiomyomatosis.";
RL   Am. J. Med. Genet. A 119:381-385(2003).
CC   -!- FUNCTION: Type IV collagen is the major structural component of
CC       glomerular basement membranes (GBM), forming a 'chicken-wire'
CC       meshwork together with laminins, proteoglycans and
CC       entactin/nidogen.
CC   -!- SUBUNIT: There are six type IV collagen isoforms, alpha 1(IV)-
CC       alpha 6(IV), each of which can form a triple helix structure with
CC       2 other chains to generate type IV collagen network.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix, basement membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P29400-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P29400-2; Sequence=VSP_001173;
CC         Note=Contains 2 extra G-X-X repeats into the triple-helix
CC         domain;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is found in kidney.
CC   -!- DOMAIN: Alpha chains of type IV collagen have a non-collagenous
CC       domain (NC1) at their C-terminus, frequent interruptions of the G-
CC       X-Y repeats in the long central triple-helical domain (which may
CC       cause flexibility in the triple helix), and a short N-terminal
CC       triple-helical 7S domain.
CC   -!- PTM: Prolines at the third position of the tripeptide repeating
CC       unit (G-X-Y) are hydroxylated in some or all of the chains.
CC   -!- PTM: Type IV collagens contain numerous cysteine residues which
CC       are involved in inter- and intramolecular disulfide bonding. 12 of
CC       these, located in the NC1 domain, are conserved in all known type
CC       IV collagens.
CC   -!- PTM: The trimeric structure of the NC1 domains is stabilized by
CC       covalent bonds between Lys and Met residues (By similarity).
CC   -!- DISEASE: Defects in COL4A5 are the cause of Alport syndrome X-
CC       linked (APSX) [MIM:301050]. APSX is characterized by progressive
CC       glomerulonephritis, renal failure, sensorineural deafness,
CC       specific eye abnormalities (lenticonous and macular flecks), and
CC       glomerular basement membrane defects. The disorder shows
CC       considerable heterogeneity in that families differ in the age of
CC       end-stage renal disease and the occurrence of deafness.
CC   -!- DISEASE: Note=Deletions covering the N-terminal regions of COL4A5
CC       and COL4A6, which are localized in a head-to-head manner, are
CC       found in the chromosome Xq22.3 centromeric deletion syndrome. This
CC       results in a phenotype with features of diffuse leiomyomatosis and
CC       Alport syndrome (DL-ATS).
CC   -!- SIMILARITY: Belongs to the type IV collagen family.
CC   -!- SIMILARITY: Contains 1 collagen IV NC1 (C-terminal non-
CC       collagenous) domain.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/COL4A5";
CC   -!- WEB RESOURCE: Name= Alport syndrome and COL4A5;
CC       URL="http://www.arup.utah.edu/database/ALPORT/ALPORT_welcome.php";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M58526; AAA99480.1; -; mRNA.
DR   EMBL; AL034369; CAA22267.2; -; Genomic_DNA.
DR   EMBL; AL031622; CAA22267.2; JOINED; Genomic_DNA.
DR   EMBL; AL035425; CAA22267.2; JOINED; Genomic_DNA.
DR   EMBL; AL035425; CAB90289.2; -; Genomic_DNA.
DR   EMBL; AL031622; CAB90289.2; JOINED; Genomic_DNA.
DR   EMBL; AL034369; CAB90289.2; JOINED; Genomic_DNA.
DR   EMBL; AL031622; CAI43038.1; -; Genomic_DNA.
DR   EMBL; AL034369; CAI43038.1; JOINED; Genomic_DNA.
DR   EMBL; AL035425; CAI43038.1; JOINED; Genomic_DNA.
DR   EMBL; AL136364; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471120; EAX02683.1; -; Genomic_DNA.
DR   EMBL; M90464; AAA52046.1; -; mRNA.
DR   EMBL; U04520; AAC27816.1; -; Genomic_DNA.
DR   EMBL; U04470; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04471; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04472; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04473; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04474; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04476; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04477; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04478; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04479; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04480; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04483; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04485; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04486; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04487; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04488; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04489; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04490; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04491; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04492; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04493; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04494; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04495; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04496; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04497; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04498; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04499; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04500; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04501; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04502; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04503; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04504; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04505; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04506; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04507; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04508; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04509; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04510; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04511; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04512; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04514; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04515; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04516; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04517; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04518; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04519; AAC27816.1; JOINED; Genomic_DNA.
DR   EMBL; U04520; AAF66217.2; -; Genomic_DNA.
DR   EMBL; U04470; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04471; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04472; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04473; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04474; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04476; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04477; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04478; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04479; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04480; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04483; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04485; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04486; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04487; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04488; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04489; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04490; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04491; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04492; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04493; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04494; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04495; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04496; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04497; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04498; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04499; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04500; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04501; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04502; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04503; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04504; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04505; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04506; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04507; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04508; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04509; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04510; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; AF199451; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; AF199452; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04511; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04512; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04514; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04515; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04516; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04517; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04518; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; U04519; AAF66217.2; JOINED; Genomic_DNA.
DR   EMBL; M63473; AAA51558.1; -; Genomic_DNA.
DR   EMBL; M63455; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63456; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63457; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63458; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63459; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63460; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63461; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63462; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63463; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63464; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63465; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63466; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63467; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63468; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63470; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63471; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M63472; AAA51558.1; JOINED; Genomic_DNA.
DR   EMBL; M31115; AAA52045.1; -; mRNA.
DR   EMBL; Z37153; CAA85512.1; -; Genomic_DNA.
DR   EMBL; S69168; AAC60612.1; -; mRNA.
DR   EMBL; S59334; AAD13909.1; -; mRNA.
DR   EMBL; S75903; AAB33374.1; -; Genomic_DNA.
DR   IPI; IPI00021715; -.
DR   IPI; IPI00216007; -.
DR   PIR; S22917; S22917.
DR   RefSeq; NP_000486.1; NM_000495.4.
DR   RefSeq; NP_203699.1; NM_033380.2.
DR   UniGene; Hs.369089; -.
DR   ProteinModelPortal; P29400; -.
DR   SMR; P29400; 1460-1685.
DR   IntAct; P29400; 2.
DR   MINT; MINT-1388512; -.
DR   STRING; P29400; -.
DR   DMDM; 461675; -.
DR   PRIDE; P29400; -.
DR   Ensembl; ENST00000361603; ENSP00000354505; ENSG00000188153.
DR   GeneID; 1287; -.
DR   KEGG; hsa:1287; -.
DR   UCSC; uc010npm.1; human.
DR   CTD; 1287; -.
DR   GeneCards; GC0XP107683; -.
DR   H-InvDB; HIX0028371; -.
DR   HGNC; HGNC:2207; COL4A5.
DR   MIM; 301050; phenotype.
DR   MIM; 303630; gene.
DR   neXtProt; NX_P29400; -.
DR   Orphanet; 88917; X-linked Alport syndrome.
DR   Orphanet; 1018; X-linked diffuse leiomyomatosis - Alport syndrome.
DR   PharmGKB; PA26722; -.
DR   eggNOG; NOG12793; -.
DR   GeneTree; ENSGT00650000093302; -.
DR   HOVERGEN; HBG004933; -.
DR   KO; K06237; -.
DR   OMA; CSPGSKC; -.
DR   PhylomeDB; P29400; -.
DR   Reactome; REACT_111045; Developmental Biology.
DR   Reactome; REACT_111102; Signal Transduction.
DR   NextBio; 5205; -.
DR   ArrayExpress; P29400; -.
DR   Bgee; P29400; -.
DR   CleanEx; HS_COL4A5; -.
DR   Genevestigator; P29400; -.
DR   GermOnline; ENSG00000188153; Homo sapiens.
DR   GO; GO:0005587; C:collagen type IV; TAS:ProtInc.
DR   GO; GO:0005488; F:binding; IEA:InterPro.
DR   GO; GO:0005201; F:extracellular matrix structural constituent; IEA:InterPro.
DR   GO; GO:0007411; P:axon guidance; TAS:Reactome.
DR   InterPro; IPR016187; C-type_lectin_fold.
DR   InterPro; IPR008160; Collagen.
DR   InterPro; IPR001442; Collagen_VI_NC.
DR   Gene3D; G3DSA:2.170.240.10; Procollagn4_C; 1.
DR   Pfam; PF01413; C4; 2.
DR   Pfam; PF01391; Collagen; 22.
DR   SMART; SM00111; C4; 2.
DR   SUPFAM; SSF56436; C-type_lectin_fold; 2.
DR   PROSITE; PS51403; NC1_IV; 1.
PE   1: Evidence at protein level;
KW   Alport syndrome; Alternative splicing; Basement membrane;
KW   Chromosomal rearrangement; Collagen; Complete proteome; Deafness;
KW   Disease mutation; Disulfide bond; Extracellular matrix; Glycoprotein;
KW   Hydroxylation; Polymorphism; Reference proteome; Repeat; Secreted;
KW   Signal.
FT   SIGNAL        1     26       Potential.
FT   CHAIN        27   1685       Collagen alpha-5(IV) chain.
FT                                /FTId=PRO_0000005852.
FT   DOMAIN     1461   1685       Collagen IV NC1.
FT   REGION       27     41       Nonhelical region (NC2).
FT   REGION       42   1456       Triple-helical region.
FT   CARBOHYD    125    125       N-linked (GlcNAc...) (Potential).
FT   DISULFID    451    451       Interchain (Potential).
FT   DISULFID    481    481       Interchain (Potential).
FT   DISULFID    484    484       Interchain (Potential).
FT   DISULFID   1476   1567       Or C-1476 with C-1564 (By similarity).
FT   DISULFID   1509   1564       Or C-1509 with C-1567 (By similarity).
FT   DISULFID   1521   1527       By similarity.
FT   DISULFID   1586   1681       Or C-1586 with C-1678 (By similarity).
FT   DISULFID   1620   1678       Or C-1620 with C-1681 (By similarity).
FT   DISULFID   1632   1638       By similarity.
FT   CROSSLNK   1549   1549       S-Lysyl-methionine sulfilimine (Met-Lys)
FT                                (interchain with K-1667) (By similarity).
FT   CROSSLNK   1667   1667       S-Lysyl-methionine sulfilimine (Lys-Met)
FT                                (interchain with M-1549) (By similarity).
FT   VAR_SEQ    1264   1264       G -> GPTGFQG (in isoform 2).
FT                                /FTId=VSP_001173.
FT   VARIANT      54     54       G -> D (in APSX; adult type).
FT                                /FTId=VAR_001914.
FT   VARIANT     114    114       G -> S (in APSX).
FT                                /FTId=VAR_007991.
FT   VARIANT     129    129       G -> E (in APSX; juvenile type).
FT                                /FTId=VAR_001915.
FT   VARIANT     129    129       G -> V (in APSX; juvenile type).
FT                                /FTId=VAR_001916.
FT   VARIANT     174    174       G -> R (in APSX).
FT                                /FTId=VAR_001917.
FT   VARIANT     177    177       G -> C (in APSX; presenting with dot-and-
FT                                fleck retinopathy).
FT                                /FTId=VAR_011220.
FT   VARIANT     177    177       G -> R (in APSX; adult type).
FT                                /FTId=VAR_001918.
FT   VARIANT     192    192       G -> R (in APSX).
FT                                /FTId=VAR_011221.
FT   VARIANT     204    204       G -> V (in APSX; juvenile type).
FT                                /FTId=VAR_011222.
FT   VARIANT     216    216       G -> R (in APSX; juvenile type).
FT                                /FTId=VAR_001919.
FT   VARIANT     219    219       G -> S (in APSX).
FT                                /FTId=VAR_001920.
FT   VARIANT     230    230       G -> R (in APSX; juvenile type).
FT                                /FTId=VAR_011223.
FT   VARIANT     239    239       G -> E (in APSX).
FT                                /FTId=VAR_011224.
FT   VARIANT     264    264       G -> R (in APSX; adult type).
FT                                /FTId=VAR_011225.
FT   VARIANT     289    289       G -> V (in APSX; juvenile type).
FT                                /FTId=VAR_001921.
FT   VARIANT     292    292       G -> R (in APSX).
FT                                /FTId=VAR_011226.
FT   VARIANT     292    292       G -> V (in APSX; juvenile type).
FT                                /FTId=VAR_001922.
FT   VARIANT     295    295       G -> D (in APSX).
FT                                /FTId=VAR_011227.
FT   VARIANT     298    298       G -> S (in APSX).
FT                                /FTId=VAR_011228.
FT   VARIANT     319    319       G -> R (in APSX; juvenile type).
FT                                /FTId=VAR_011229.
FT   VARIANT     325    325       G -> E (in APSX).
FT                                /FTId=VAR_001923.
FT   VARIANT     325    325       G -> R (in APSX; juvenile and adult
FT                                types).
FT                                /FTId=VAR_001924.
FT   VARIANT     331    331       G -> V (in APSX).
FT                                /FTId=VAR_007992.
FT   VARIANT     365    367       Missing (in APSX; juvenile type).
FT                                /FTId=VAR_001926.
FT   VARIANT     365    365       G -> E (in APSX; juvenile type).
FT                                /FTId=VAR_001925.
FT   VARIANT     371    371       G -> E (in APSX; juvenile type).
FT                                /FTId=VAR_001927.
FT   VARIANT     374    374       G -> A (in APSX).
FT                                /FTId=VAR_001928.
FT   VARIANT     383    383       G -> D (in APSX; juvenile type).
FT                                /FTId=VAR_001929.
FT   VARIANT     400    400       G -> E (in APSX; adult type).
FT                                /FTId=VAR_001930.
FT   VARIANT     406    406       G -> V (in APSX; adult type).
FT                                /FTId=VAR_001931.
FT   VARIANT     409    409       G -> D (in APSX).
FT                                /FTId=VAR_001932.
FT   VARIANT     412    412       G -> V (in APSX; adult type).
FT                                /FTId=VAR_011230.
FT   VARIANT     415    415       G -> R (in APSX).
FT                                /FTId=VAR_011231.
FT   VARIANT     420    420       G -> E (in APSX; juvenile type).
FT                                /FTId=VAR_011232.
FT   VARIANT     420    420       G -> V (in APSX).
FT                                /FTId=VAR_011233.
FT   VARIANT     423    423       G -> E (in APSX).
FT                                /FTId=VAR_011234.
FT   VARIANT     430    430       A -> D.
FT                                /FTId=VAR_001933.
FT   VARIANT     444    444       I -> S (in dbSNP:rs2272946).
FT                                /FTId=VAR_001934.
FT   VARIANT     456    458       Missing (in APSX).
FT                                /FTId=VAR_001935.
FT   VARIANT     466    466       G -> E (in APSX).
FT                                /FTId=VAR_001936.
FT   VARIANT     472    472       G -> R (in APSX).
FT                                /FTId=VAR_007993.
FT   VARIANT     491    491       G -> E (in APSX; juvenile type).
FT                                /FTId=VAR_011235.
FT   VARIANT     494    494       G -> D (in APSX; adult type).
FT                                /FTId=VAR_001937.
FT   VARIANT     496    507       Missing (in APSX; juvenile type).
FT                                /FTId=VAR_001938.
FT   VARIANT     497    497       G -> C (in APSX; adult type).
FT                                /FTId=VAR_011236.
FT   VARIANT     521    521       G -> C (in APSX).
FT                                /FTId=VAR_001939.
FT   VARIANT     521    521       G -> S (in APSX).
FT                                /FTId=VAR_001940.
FT   VARIANT     524    524       G -> D (in APSX; adult type).
FT                                /FTId=VAR_011237.
FT   VARIANT     545    545       G -> R (in APSX).
FT                                /FTId=VAR_007994.
FT   VARIANT     545    545       G -> V (in APSX).
FT                                /FTId=VAR_007995.
FT   VARIANT     558    558       G -> R (in APSX).
FT                                /FTId=VAR_011238.
FT   VARIANT     561    561       G -> R (in APSX).
FT                                /FTId=VAR_007996.
FT   VARIANT     567    567       G -> A (in APSX; juvenile type).
FT                                /FTId=VAR_001941.
FT   VARIANT     573    573       G -> D (in APSX).
FT                                /FTId=VAR_011239.
FT   VARIANT     579    579       G -> E (in APSX).
FT                                /FTId=VAR_011240.
FT   VARIANT     579    579       G -> R (in APSX; adult type).
FT                                /FTId=VAR_007997.
FT   VARIANT     603    603       G -> V (in APSX).
FT                                /FTId=VAR_011241.
FT   VARIANT     609    609       G -> R (in APSX; juvenile type).
FT                                /FTId=VAR_011242.
FT   VARIANT     609    609       G -> V (in APSX; juvenile type).
FT                                /FTId=VAR_001942.
FT   VARIANT     619    619       P -> S.
FT                                /FTId=VAR_011243.
FT   VARIANT     621    621       G -> C (in APSX).
FT                                /FTId=VAR_011244.
FT   VARIANT     624    624       G -> D (in APSX).
FT                                /FTId=VAR_011245.
FT   VARIANT     629    629       G -> D (in APSX).
FT                                /FTId=VAR_011246.
FT   VARIANT     632    632       G -> D (in APSX).
FT                                /FTId=VAR_011247.
FT   VARIANT     633    633       E -> K (in APSX).
FT                                /FTId=VAR_011248.
FT   VARIANT     635    635       G -> D (in APSX).
FT                                /FTId=VAR_007998.
FT   VARIANT     638    638       G -> A (in APSX).
FT                                /FTId=VAR_001944.
FT   VARIANT     638    638       G -> S (in APSX; juvenile type).
FT                                /FTId=VAR_007999.
FT   VARIANT     638    638       G -> V (in APSX).
FT                                /FTId=VAR_001943.
FT   VARIANT     653    653       G -> R (in APSX; juvenile type).
FT                                /FTId=VAR_001945.
FT   VARIANT     664    664       K -> N (in dbSNP:rs34077552).
FT                                /FTId=VAR_001946.
FT   VARIANT     669    669       G -> A (in APSX; juvenile type).
FT                                /FTId=VAR_008000.
FT   VARIANT     681    681       G -> D (in APSX).
FT                                /FTId=VAR_011249.
FT   VARIANT     684    684       G -> V (in APSX; adult type).
FT                                /FTId=VAR_001947.
FT   VARIANT     687    687       G -> E (in APSX).
FT                                /FTId=VAR_008001.
FT   VARIANT     722    722       G -> E (in APSX).
FT                                /FTId=VAR_011250.
FT   VARIANT     739    739       P -> A.
FT                                /FTId=VAR_011251.
FT   VARIANT     739    739       P -> S (in APSX; juvenile type).
FT                                /FTId=VAR_011252.
FT   VARIANT     740    740       G -> E (in APSX; juvenile type).
FT                                /FTId=VAR_001948.
FT   VARIANT     743    743       G -> D (in APSX).
FT                                /FTId=VAR_008002.
FT   VARIANT     772    772       G -> D (in APSX; juvenile type).
FT                                /FTId=VAR_001949.
FT   VARIANT     796    796       G -> R (in APSX).
FT                                /FTId=VAR_001950.
FT   VARIANT     802    807       Missing (in APSX).
FT                                /FTId=VAR_011254.
FT   VARIANT     802    802       G -> R (in APSX).
FT                                /FTId=VAR_011253.
FT   VARIANT     808    808       G -> E (in APSX; adult type).
FT                                /FTId=VAR_008003.
FT   VARIANT     811    811       G -> V (in APSX; juvenile type).
FT                                /FTId=VAR_011255.
FT   VARIANT     822    824       Missing (in APSX).
FT                                /FTId=VAR_008004.
FT   VARIANT     822    822       G -> R (in APSX).
FT                                /FTId=VAR_011256.
FT   VARIANT     852    852       G -> E (in APSX; juvenile type).
FT                                /FTId=VAR_008005.
FT   VARIANT     852    852       G -> R (in APSX).
FT                                /FTId=VAR_001951.
FT   VARIANT     864    875       Missing (in APSX).
FT                                /FTId=VAR_011257.
FT   VARIANT     866    866       G -> E (in APSX; adult type).
FT                                /FTId=VAR_001952.
FT   VARIANT     869    869       G -> R (in APSX; juvenile type).
FT                                /FTId=VAR_001953.
FT   VARIANT     872    872       G -> R (in APSX).
FT                                /FTId=VAR_001954.
FT   VARIANT     878    878       G -> R (in APSX).
FT                                /FTId=VAR_008006.
FT   VARIANT     898    898       M -> V (in APSX; mild phenotype).
FT                                /FTId=VAR_011258.
FT   VARIANT     902    902       G -> V (in APSX; juvenile type).
FT                                /FTId=VAR_011259.
FT   VARIANT     911    911       G -> E (in APSX).
FT                                /FTId=VAR_011260.
FT   VARIANT     941    941       G -> C (in APSX).
FT                                /FTId=VAR_011261.
FT   VARIANT     942    942       Missing (in APSX).
FT                                /FTId=VAR_001955.
FT   VARIANT     947    947       G -> D (in APSX).
FT                                /FTId=VAR_011262.
FT   VARIANT     953    953       G -> V (in APSX; found on the same allele
FT                                as variant Glu-1211).
FT                                /FTId=VAR_011263.
FT   VARIANT     988    992       Missing (in APSX; adult type).
FT                                /FTId=VAR_008007.
FT   VARIANT    1006   1006       G -> A (in APSX).
FT                                /FTId=VAR_011264.
FT   VARIANT    1006   1006       G -> V (in APSX).
FT                                /FTId=VAR_011265.
FT   VARIANT    1015   1015       G -> E (in APSX).
FT                                /FTId=VAR_011266.
FT   VARIANT    1015   1015       G -> V (in APSX).
FT                                /FTId=VAR_011267.
FT   VARIANT    1030   1030       G -> S (in APSX).
FT                                /FTId=VAR_011268.
FT   VARIANT    1036   1036       G -> V (in APSX).
FT                                /FTId=VAR_011269.
FT   VARIANT    1039   1039       G -> S (in APSX; juvenile type).
FT                                /FTId=VAR_011270.
FT   VARIANT    1045   1045       G -> E (in APSX).
FT                                /FTId=VAR_011271.
FT   VARIANT    1066   1066       G -> R (in APSX).
FT                                /FTId=VAR_011272.
FT   VARIANT    1066   1066       G -> S (in APSX).
FT                                /FTId=VAR_011273.
FT   VARIANT    1086   1086       G -> D (in APSX).
FT                                /FTId=VAR_011274.
FT   VARIANT    1104   1104       G -> V (in APSX).
FT                                /FTId=VAR_001956.
FT   VARIANT    1107   1107       G -> R (in APSX).
FT                                /FTId=VAR_008008.
FT   VARIANT    1143   1143       G -> D (in APSX; juvenile type).
FT                                /FTId=VAR_001957.
FT   VARIANT    1143   1143       G -> S (in APSX; adult type).
FT                                /FTId=VAR_001958.
FT   VARIANT    1158   1158       G -> R (in APSX).
FT                                /FTId=VAR_011275.
FT   VARIANT    1161   1161       G -> R (in APSX).
FT                                /FTId=VAR_008009.
FT   VARIANT    1167   1167       G -> S (in APSX).
FT                                /FTId=VAR_011276.
FT   VARIANT    1170   1170       G -> S (in APSX).
FT                                /FTId=VAR_011277.
FT   VARIANT    1182   1182       G -> R (in APSX; juvenile type).
FT                                /FTId=VAR_001959.
FT   VARIANT    1196   1196       G -> R (in APSX).
FT                                /FTId=VAR_011278.
FT   VARIANT    1205   1205       G -> C (in APSX; juvenile type).
FT                                /FTId=VAR_011279.
FT   VARIANT    1211   1211       G -> E (in APSX; found on the same allele
FT                                as variant Val-953).
FT                                /FTId=VAR_011280.
FT   VARIANT    1211   1211       G -> R (in APSX).
FT                                /FTId=VAR_008010.
FT   VARIANT    1220   1220       G -> D (in APSX).
FT                                /FTId=VAR_008011.
FT   VARIANT    1229   1229       G -> D (in APSX; adult type).
FT                                /FTId=VAR_011281.
FT   VARIANT    1241   1241       G -> C (in APSX).
FT                                /FTId=VAR_001960.
FT   VARIANT    1244   1244       G -> D (in APSX).
FT                                /FTId=VAR_011282.
FT   VARIANT    1252   1252       G -> S (in APSX; adult type).
FT                                /FTId=VAR_011283.
FT   VARIANT    1261   1261       G -> E (in APSX).
FT                                /FTId=VAR_011284.
FT   VARIANT    1270   1270       G -> S (in APSX).
FT                                /FTId=VAR_001961.
FT   VARIANT    1333   1333       G -> S (in APSX).
FT                                /FTId=VAR_008012.
FT   VARIANT    1357   1357       G -> S (in APSX).
FT                                /FTId=VAR_011285.
FT   VARIANT    1379   1379       G -> V (in APSX; adult type).
FT                                /FTId=VAR_001962.
FT   VARIANT    1410   1410       R -> C (in APSX; adult and juvenile
FT                                types).
FT                                /FTId=VAR_001963.
FT   VARIANT    1421   1421       G -> W (in APSX; adult type).
FT                                /FTId=VAR_001964.
FT   VARIANT    1422   1422       R -> C (in APSX; juvenile type).
FT                                /FTId=VAR_001965.
FT   VARIANT    1427   1427       G -> V (in APSX; adult type).
FT                                /FTId=VAR_008013.
FT   VARIANT    1428   1428       L -> M.
FT                                /FTId=VAR_011286.
FT   VARIANT    1442   1442       G -> D (in APSX).
FT                                /FTId=VAR_008014.
FT   VARIANT    1451   1451       G -> S (in APSX).
FT                                /FTId=VAR_001966.
FT   VARIANT    1486   1486       G -> A (in APSX; adult type).
FT                                /FTId=VAR_008015.
FT   VARIANT    1488   1488       S -> F (in APSX).
FT                                /FTId=VAR_011287.
FT   VARIANT    1498   1498       A -> D (in APSX).
FT                                /FTId=VAR_001967.
FT   VARIANT    1511   1511       R -> H (in APSX; juvenile type; could be
FT                                a non pathogenic variant).
FT                                /FTId=VAR_011288.
FT   VARIANT    1517   1517       P -> T (in APSX; juvenile type).
FT                                /FTId=VAR_001968.
FT   VARIANT    1538   1538       W -> S (in APSX; adult type).
FT                                /FTId=VAR_001969.
FT   VARIANT    1559   1559       P -> A.
FT                                /FTId=VAR_008016.
FT   VARIANT    1563   1563       R -> Q (in APSX).
FT                                /FTId=VAR_001970.
FT   VARIANT    1564   1564       C -> S (in APSX; adult type).
FT                                /FTId=VAR_001971.
FT   VARIANT    1567   1567       C -> R (in APSX; juvenile type).
FT                                /FTId=VAR_011289.
FT   VARIANT    1596   1596       G -> D (in APSX).
FT                                /FTId=VAR_001972.
FT   VARIANT    1597   1685       Missing (in APSX).
FT                                /FTId=VAR_019594.
FT   VARIANT    1649   1649       L -> R (in APSX; adult type).
FT                                /FTId=VAR_001973.
FT   VARIANT    1677   1677       R -> P (in APSX).
FT                                /FTId=VAR_011290.
FT   VARIANT    1677   1677       R -> Q (in APSX).
FT                                /FTId=VAR_001974.
FT   VARIANT    1678   1678       C -> W (in APSX).
FT                                /FTId=VAR_011291.
FT   VARIANT    1679   1685       Missing (in APSX).
FT                                /FTId=VAR_019595.
FT   CONFLICT    440    441       AG -> GS (in Ref. 5; AAA99480).
FT   CONFLICT    625    628       FGPP -> LALQ (in Ref. 5; AAA99480).
FT   CONFLICT    667    668       LP -> FR (in Ref. 5; AAA99480).
FT   CONFLICT    888    888       A -> R (in Ref. 5; AAA99480).
SQ   SEQUENCE   1685 AA;  161044 MW;  4450A6762F12A626 CRC64;
     MKLRGVSLAA GLFLLALSLW GQPAEAAACY GCSPGSKCDC SGIKGEKGER GFPGLEGHPG
     LPGFPGPEGP PGPRGQKGDD GIPGPPGPKG IRGPPGLPGF PGTPGLPGMP GHDGAPGPQG
     IPGCNGTKGE RGFPGSPGFP GLQGPPGPPG IPGMKGEPGS IIMSSLPGPK GNPGYPGPPG
     IQGLPGPTGI PGPIGPPGPP GLMGPPGPPG LPGPKGNMGL NFQGPKGEKG EQGLQGPPGP
     PGQISEQKRP IDVEFQKGDQ GLPGDRGPPG PPGIRGPPGP PGGEKGEKGE QGEPGKRGKP
     GKDGENGQPG IPGLPGDPGY PGEPGRDGEK GQKGDTGPPG PPGLVIPRPG TGITIGEKGN
     IGLPGLPGEK GERGFPGIQG PPGLPGPPGA AVMGPPGPPG FPGERGQKGD EGPPGISIPG
     PPGLDGQPGA PGLPGPPGPA GPHIPPSDEI CEPGPPGPPG SPGDKGLQGE QGVKGDKGDT
     CFNCIGTGIS GPPGQPGLPG LPGPPGSLGF PGQKGEKGQA GATGPKGLPG IPGAPGAPGF
     PGSKGEPGDI LTFPGMKGDK GELGSPGAPG LPGLPGTPGQ DGLPGLPGPK GEPGGITFKG
     ERGPPGNPGL PGLPGNIGPM GPPGFGPPGP VGEKGIQGVA GNPGQPGIPG PKGDPGQTIT
     QPGKPGLPGN PGRDGDVGLP GDPGLPGQPG LPGIPGSKGE PGIPGIGLPG PPGPKGFPGI
     PGPPGAPGTP GRIGLEGPPG PPGFPGPKGE PGFALPGPPG PPGLPGFKGA LGPKGDRGFP
     GPPGPPGRTG LDGLPGPKGD VGPNGQPGPM GPPGLPGIGV QGPPGPPGIP GPIGQPGLHG
     IPGEKGDPGP PGLDVPGPPG ERGSPGIPGA PGPIGPPGSP GLPGKAGASG FPGTKGEMGM
     MGPPGPPGPL GIPGRSGVPG LKGDDGLQGQ PGLPGPTGEK GSKGEPGLPG PPGPMDPNLL
     GSKGEKGEPG LPGIPGVSGP KGYQGLPGDP GQPGLSGQPG LPGPPGPKGN PGLPGQPGLI
     GPPGLKGTIG DMGFPGPQGV EGPPGPSGVP GQPGSPGLPG QKGDKGDPGI SSIGLPGLPG
     PKGEPGLPGY PGNPGIKGSV GDPGLPGLPG TPGAKGQPGL PGFPGTPGPP GPKGISGPPG
     NPGLPGEPGP VGGGGHPGQP GPPGEKGKPG QDGIPGPAGQ KGEPGQPGFG NPGPPGLPGL
     SGQKGDGGLP GIPGNPGLPG PKGEPGFHGF PGVQGPPGPP GSPGPALEGP KGNPGPQGPP
     GRPGLPGPEG PPGLPGNGGI KGEKGNPGQP GLPGLPGLKG DQGPPGLQGN PGRPGLNGMK
     GDPGLPGVPG FPGMKGPSGV PGSAGPEGEP GLIGPPGPPG LPGPSGQSII IKGDAGPPGI
     PGQPGLKGLP GPQGPQGLPG PTGPPGDPGR NGLPGFDGAG GRKGDPGLPG QPGTRGLDGP
     PGPDGLQGPP GPPGTSSVAH GFLITRHSQT TDAPQCPQGT LQVYEGFSLL YVQGNKRAHG
     QDLGTAGSCL RRFSTMPFMF CNINNVCNFA SRNDYSYWLS TPEPMPMSMQ PLKGQSIQPF
     ISRCAVCEAP AVVIAVHSQT IQIPHCPQGW DSLWIGYSFM MHTSAGAEGS GQALASPGSC
     LEEFRSAPFI ECHGRGTCNY YANSYSFWLA TVDVSDMFSK PQSETLKAGD LRTRISRCQV
     CMKRT
//
